1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Petit, M.C. Benkirane, N. Guichard, G. Phan Chan Du, A. Cung, M.T. Briand, J.P. Muller, S. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 D-ALANINE D-peptide linking C6 H15 N4 O2 1 175.209 D-ARGININE D-peptide linking C4 H7 N O4 133.103 D-ASPARTIC ACID D-peptide linking C5 H10 N2 O3 146.144 D-GLUTAMINE D-peptide linking C6 H13 N O2 131.173 D-LEUCINE D-peptide linking C9 H11 N O2 165.189 D-PHENYLALANINE D-peptide linking C5 H9 N O2 115.130 D-PROLINE D-peptide linking C3 H7 N O3 105.093 D-SERINE D-peptide linking C5 H11 N O2 117.146 D-VALINE D-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C7 H12 O4 160.168 ISOBUTYL MALONIC ACID non-polymer H2 N 16.023 AMINO GROUP non-polymer US J.Biol.Chem. JBCHA3 0071 0021-9258 274 3686 3692 10.1074/jbc.274.6.3686 9920919 Solution structure of a retro-inverso peptide analogue mimicking the foot-and-mouth disease virus major antigenic site. Structural basis for its antigenic cross-reactivity with the parent peptide. 1999 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 RETRO-INVERSO PEPTIDE CORRESPONDING TO THE MAJOR IMMUNOGEN REGION OF THE FOOT-AND-MOUTH-DISEASE VIRUS CAPSID 1973.200 VP1 PROTEIN THE MAJOR IMMUNOGEN REGION, RESIDUES 141-159 1 man polymer no yes (LML)(DGN)(DAR)(DAL)(DVA)(DAR)(DPR)(DAL)(DLE)(DSN)G(DPN)(DAS)G(DAR)(DVA)G(DSN)G (NH2) XQRAVRPALSGFDGRVGSGX A polypeptide(L) n n n n n n n n n n n n n n n n n n n n pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list struct_conf repository Initial release Version format compliance Version format compliance Derived calculations Other 1 0 1999-01-13 1 1 2008-03-27 1 2 2011-07-13 1 3 2017-11-29 _pdbx_database_status.process_site Y BNL 1998-05-22 REL REL LEAST RESTRAINTS VIOLATIONS, TARGET FUNCTION 50 10 COSY TOCSY NOESY ROESY 0.1 M PHOSPHATE 5.7 1 atm 285 K RESTRAINT ENERGY MINIMIZATION TORSION ANGLE DYNAMICS, ANNEALING, MINIMIZATION 90% H2O:10% D2O GUNTERT,WUTHRICH refinement DYANA 1.4 structure solution DYANA 1.4 400 Bruker DRX400 LML 159 n 1 LML 159 A DGN 158 n 2 DGN 158 A DAR 157 n 3 DAR 157 A DAL 156 n 4 DAL 156 A DVA 155 n 5 DVA 155 A DAR 154 n 6 DAR 154 A DPR 153 n 7 DPR 153 A DAL 152 n 8 DAL 152 A DLE 151 n 9 DLE 151 A DSN 150 n 10 DSN 150 A GLY 149 n 11 GLY 149 A DPN 148 n 12 DPN 148 A DSP 147 n 13 DAS 147 A GLY 146 n 14 GLY 146 A DAR 145 n 15 DAR 145 A DVA 144 n 16 DVA 144 A GLY 143 n 17 GLY 143 A DSN 142 n 18 DSN 142 A GLY 141 n 19 GLY 141 A NH2 140 n 20 NH2 140 A author_defined_assembly 1 monomeric A DGN 158 D-GLUTAMINE A DGN 2 GLN A DAR 157 D-ARGININE A DAR 3 ARG A DAL 156 D-ALANINE A DAL 4 ALA A DVA 155 D-VALINE A DVA 5 VAL A DAR 154 D-ARGININE A DAR 6 ARG A DPR 153 D-PROLINE A DPR 7 PRO A DAL 152 D-ALANINE A DAL 8 ALA A DLE 151 D-LEUCINE A DLE 9 LEU A DSN 150 D-SERINE A DSN 10 SER A DAS 147 D-ASPARTIC ACID A DAS 13 ASP A DAR 145 D-ARGININE A DAR 15 ARG A DVA 144 D-VALINE A DVA 16 VAL A DSN 142 D-SERINE A DSN 18 SER 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 1 A DGN 158 127.25 72.91 1 A DAR 157 144.31 70.43 1 A DAL 156 154.87 -69.39 1 A DLE 151 132.44 77.82 1 A DAS 147 165.48 -69.26 1 A DSN 142 163.99 -99.89 2 A DAR 157 144.44 70.33 2 A DAL 156 166.60 -69.92 2 A DAR 154 170.34 -62.68 2 A DAL 152 42.67 -98.41 2 A DLE 151 142.64 55.53 2 A DSN 150 152.73 -85.71 2 A DAS 147 165.88 -66.18 2 A DAR 145 170.52 -116.76 2 A DVA 144 69.41 -98.66 3 A DAR 157 169.20 84.36 3 A DAL 156 157.29 -68.56 3 A DAR 154 170.58 -65.04 3 A DAL 152 25.13 -95.02 3 A DSN 150 36.87 -108.17 3 A DAS 147 164.18 -67.84 3 A DAR 145 170.42 -141.52 4 A DGN 158 125.66 154.41 4 A DAR 157 95.86 83.24 4 A DLE 151 131.99 65.01 4 A DPN 148 37.79 -157.55 4 A DAS 147 163.68 -65.30 4 A DAR 145 27.77 -97.08 5 A DAR 154 170.82 -59.69 5 A DAL 152 9.04 -90.67 5 A DLE 151 146.67 42.79 5 A DSN 150 170.44 -132.29 5 A DAS 147 166.53 -69.32 5 A DAR 145 170.47 -141.40 5 A DSN 142 166.37 -109.68 6 A DAR 157 165.06 83.68 6 A DAL 152 57.00 -106.80 6 A DLE 151 140.47 58.05 6 A DAS 147 168.26 -58.74 6 A DAR 145 170.50 -141.50 6 A DSN 142 164.26 -112.56 7 A DAL 156 170.27 -66.15 7 A DAR 154 170.07 -62.90 7 A DAL 152 52.14 -95.39 7 A DLE 151 139.09 70.03 7 A DAS 147 166.24 -64.55 7 A DAR 145 170.75 -109.34 7 A DVA 144 55.09 -91.43 8 A DGN 158 125.56 154.30 8 A DAR 157 37.48 83.55 8 A DAR 154 170.37 -62.66 8 A DAL 152 41.12 -97.98 8 A DLE 151 144.10 48.54 8 A DAS 147 163.73 -70.49 8 A DAR 145 170.55 -116.71 8 A DSN 142 170.30 -131.98 9 A DAR 157 169.12 83.66 9 A DAR 154 170.16 -62.55 9 A DAL 152 53.73 -97.13 9 A DLE 151 138.93 51.57 9 A DAS 147 164.60 -71.05 9 A DAR 145 170.46 -141.54 10 A DGN 158 170.05 40.52 10 A DAR 157 149.04 83.65 10 A DAR 154 171.47 -64.07 10 A DAL 152 49.47 -94.14 10 A DLE 151 141.23 49.79 10 A DAS 147 165.12 -71.31 10 A DAR 145 170.08 -137.20 model building DYANA refinement DYANA VP1 PROTEIN RETRO-INVERSO ANALOGUE OF THE G-H LOOP OF VP1 IN FOOT-AND-MOUTH-DISEASE (FMD) VIRUS, NMR, 10 STRUCTURES 1 Y N covale 1.325 A LML 159 A C LML 1 1_555 A DGN 158 A N DGN 2 1_555 covale 1.325 A DGN 158 A C DGN 2 1_555 A DAR 157 A N DAR 3 1_555 covale 1.325 A DAR 157 A C DAR 3 1_555 A DAL 156 A N DAL 4 1_555 covale 1.325 A DAL 156 A C DAL 4 1_555 A DVA 155 A N DVA 5 1_555 covale 1.326 A DVA 155 A C DVA 5 1_555 A DAR 154 A N DAR 6 1_555 covale 1.360 A DAR 154 A C DAR 6 1_555 A DPR 153 A N DPR 7 1_555 covale 1.325 A DPR 153 A C DPR 7 1_555 A DAL 152 A N DAL 8 1_555 covale 1.325 A DAL 152 A C DAL 8 1_555 A DLE 151 A N DLE 9 1_555 covale 1.325 A DLE 151 A C DLE 9 1_555 A DSN 150 A N DSN 10 1_555 covale 1.324 A DSN 150 A C DSN 10 1_555 A GLY 149 A N GLY 11 1_555 covale 1.325 A DPN 148 A N DPN 12 1_555 A GLY 149 A C GLY 11 1_555 covale 1.325 A DPN 148 A C DPN 12 1_555 A DAS 147 A N DAS 13 1_555 covale 1.325 A DAS 147 A C DAS 13 1_555 A GLY 146 A N GLY 14 1_555 covale 1.325 A DAR 145 A N DAR 15 1_555 A GLY 146 A C GLY 14 1_555 covale 1.326 A DAR 145 A C DAR 15 1_555 A DVA 144 A N DVA 16 1_555 covale 1.325 A DVA 144 A C DVA 16 1_555 A GLY 143 A N GLY 17 1_555 covale 1.325 A DSN 142 A N DSN 18 1_555 A GLY 143 A C GLY 17 1_555 covale 1.325 A DSN 142 A C DSN 18 1_555 A GLY 141 A N GLY 19 1_555 covale 1.326 A NH2 140 A N NH2 20 1_555 A GLY 141 A C GLY 19 1_555 VIRAL PROTEIN CAPSID, PEPTIDOMIMETIC, RETRO-INVERSO, FMDV, ANTIGEN, Viral protein 1BFW PDB 1 1BFW 159 140 1BFW 159 140 1BFW A 1 1 20 1 P 1